Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-01-21

Clinical Trial Update: Manipulation of Visceral Hypersensitivity With Probiotic Bacteria in Irritable Bowel Syndrome [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating manipulation of visceral hypersensitivity with probiotic bacteria in irritable bowel syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Probiotic bacteria (unspecified)

Snippet

Sponsor: Chinese University of Hong Kong | Conditions: Irritable Bowel Syndrome | Phase 4 | Status: COMPLETED